| Name | (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid |
|---|---|
| Synonyms |
D-LeuFmoc-OH
Fmoc-Leu-OH N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-leucine EINECS 252-662-7 (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic acid MFCD00037133 Tocris-0675 FMOC-D-LEU Fmoc-D-Leu-OH Fmoc-L-leucine Fmoc-L-Leu-OH L-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-leucine Fmoc-D-leucine-OH N-Fmoc-D-leucine D-Fmoc-Leu-OH N-Fmoc-L-leucine D-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- Fmoc-D-Leucine N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucine |
| Description | Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity[1]. |
|---|---|
| Related Catalog | |
| Target |
PPARγ |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 559.8±33.0 °C at 760 mmHg |
| Melting Point | 152-156 °C(lit.) |
| Molecular Formula | C21H23NO4 |
| Molecular Weight | 353.412 |
| Flash Point | 292.4±25.4 °C |
| Exact Mass | 353.162720 |
| PSA | 75.63000 |
| LogP | 4.95 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.583 |
| Storage condition | 2~8°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2924299090 |
| Precursor 7 | |
|---|---|
| DownStream 10 | |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |